← FDA DRUG APPROVALS

FDA ANDA · ANDA075043

HYDROCORTISONE VALERATE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA075043
TYPE
ANDA
ORIGINAL APPROVAL
1998-08-25
LATEST ACTION
2003-08-04
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

HYDROCORTISONE VALERATEPrescription
HYDROCORTISONE VALERATE 0.2% · OINTMENT · TOPICAL

Approval history

2003-08-04Labeling · Supplement 5AP
2002-07-29Manufacturing (CMC) · Supplement 3AP
2001-04-27Manufacturing (CMC) · Supplement 2AP
1998-12-21Manufacturing (CMC) · Supplement 1AP
1998-08-25OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →